Lowering Albuminuria Improves Survival and Kidney Outcomes in Diabetes-Related CKD: Study
A recent analysis published in BMJ Open Diabetes Research & Care revealed that reducing albuminuria plays a crucial role in improving long-term outcomes for patients living with chronic kidney disease and type 2 diabetes mellitus. The study demonstrated that patients who achieved a sustained decrease of more than thirty percent in the urine albumin-to-creatinine ratio over a period of six to twenty-four months experienced significantly lower risks of death, cardiovascular events, and kidney disease progression. These results highlight that albuminuria is not only a marker of kidney damage but also a modifiable treatment target capable of influencing overall survival.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!